HomeCompareBRLXF vs JNJ

BRLXF vs JNJ: Dividend Comparison 2026

BRLXF yields 1.81% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $8.1K in total portfolio value· pulled ahead in Year 7
10 years
BRLXF
BRLXF
● Live price
1.81%
Share price
$26.43
Annual div
$0.48
5Y div CAGR
-1.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.1K
Annual income
$176.88
Full BRLXF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — BRLXF vs JNJ

📍 JNJ pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBRLXFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BRLXF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BRLXF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRLXF
Annual income on $10K today (after 15% tax)
$153.48/yr
After 10yr DRIP, annual income (after tax)
$150.35/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,835.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRLXF + JNJ for your $10,000?

BRLXF: 50%JNJ: 50%
100% JNJ50/50100% BRLXF
Portfolio after 10yr
$26.2K
Annual income
$2,433.14/yr
Blended yield
9.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BRLXF
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
0.6
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRLXF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBRLXFJNJ
Forward yield1.81%2.13%
Annual dividend / share$0.48$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-1.3%28%
Portfolio after 10y$22.1K$30.3K
Annual income after 10y$176.88$4,689.40
Total dividends collected$1.8K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: BRLXF vs JNJ ($10,000, DRIP)

YearBRLXF PortfolioBRLXF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,878$178.22$10,592$272.30+$286.00BRLXF
2$11,819$178.83$11,289$357.73+$530.00BRLXF
3$12,825$179.22$12,123$472.89+$702.00BRLXF
4$13,902$179.40$13,141$629.86+$761.00BRLXF
5$15,055$179.38$14,408$846.81+$647.00BRLXF
6$16,288$179.18$16,021$1,151.60+$267.00BRLXF
7← crossover$17,607$178.82$18,122$1,588.22$515.00JNJ
8$19,017$178.31$20,930$2,228.20$1.9KJNJ
9$20,526$177.65$24,792$3,191.91$4.3KJNJ
10$22,140$176.88$30,274$4,689.40$8.1KJNJ

BRLXF vs JNJ: Complete Analysis 2026

BRLXFStock

Boralex Inc., together with its subsidiaries, engages in the development, construction, and operation of renewable energy power facilities primarily in Canada, France, and the United States. As of December 31, 2021, the company had interests in 90 wind power stations with an installed capacity of 2,032 megawatts (MW); 16 hydroelectric power stations with a capacity of 181 MW; 12 solar power stations with an installed capacity of 244 MW; and one thermal power station with an installed capacity of 35 MW. It also operates two hydroelectric power stations on behalf of R.S.P. Énergie Inc. Boralex Inc. was incorporated in 1982 and is headquartered in Kingsey Falls, Canada.

Full BRLXF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BRLXF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRLXF vs SCHDBRLXF vs JEPIBRLXF vs OBRLXF vs KOBRLXF vs MAINBRLXF vs ABBVBRLXF vs MRKBRLXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.